DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Setoperone
Setoperone
United States Patent (19) 11 Patent Number: 5,902,815 Olney Et Al
Fushi-Tarazu During Segmentation
(12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
Decrease in Brain Serotonin 2 Receptor Binding In
A New Framework for Investigating Antipsychotic Action in Humans: Lessons from PET Imaging S Kapur
Name and Address of the Sponsor and Monitor
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Clinical Pharmacokinetics 41
A Positron Emission Tomography Study Of
Drug Development in Alzheimer's Disease: the Contribution of PET and SPECT
Stembook 2018.Pdf
New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A
Serotonin Receptor and Transporter Ligands – Current Status
New Insights Into the Biology of Schizophrenia Through the Mechanism of Action of Clozapine
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Do Novel Antipsychotics Have Similar Pharmacological Characteristics? a Review of the Evidence J
Top View
Significant Dissociation of Brain and Plasma Kinetics with Antipsychotics
Receptor Effects of Antipsychotics
Progress Report 6/1/10 2009 Molecular Imaging Research Grant for Junior Medical Faculty Laura L
UC Davis UC Davis Previously Published Works
Pharmacogenetics of Antidepressants and Antipsychotics
Customs Tariff - Schedule Xxi - 1
Recent Concepts in Clinical Psychiatry: Drug Treatment in Schizophrenia
List of Participants
Wo 2007/044693 A2
United States Patent (19) 11 Patent Number: 5,955,459 Bradley Et Al
Occupancy of Striatal and Extrastriatal Dopamine D2/D3 Receptors by Olanzapine and Haloperidol
Targeting the Dopamine D Receptor in Schizophrenia
A Roadmap for Development of Novel Antipsychotic Agents Based on a Risperidone Scaffold
(12) United States Patent (10) Patent No.: US 6,680,047 B2 Klaveness Et Al
43 Antidepressants Maurizio Fava, MD, and George I
Emerging Technologies and New Directions in Drug Abuse Research
Sleep Apnea and CMV Driver Safety
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
An [ F]Setoperone PET Study
Pharmaceutical Appendix to the Tariff Schedule 2
Parametric PET Imaging of 5Ht2areceptor Distribution with 18F-Setoperone in the Normal Human Neocortex
A Positron Emission Tomography Study of Quetiapine in Schizophrenia: a Preliminary Finding of an Antipsychotic Effect with Only
Harmonized Tariff Schedule of the United States (2006) (Rev
Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
Serotonin 5-HT2 Receptors in Schizophrenia: a PET Study Using [18F]Setoperone in Neuroleptic-Naive Patients and Normal Subjects
Neuroleptanalgesia for Acute Abdominal Pain: a Systematic Review
Effects of Rapid Tryptophan Depletion on Brain 5-HT2 Receptors
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Genetics and Antidepressant: Where We Are